Pharmena S.A. (PHR) — Cash Flow-to-Debt Ratio
Pharmena S.A. (PHR) has a Cash Flow-to-Debt Ratio of -0.96x as of September 2025, meaning its operating cash flow of zł-820.00K could theoretically repay -1% of its total liabilities (zł850.00K) in one year. Check total reinvestment intensity of Pharmena S.A. to assess the company's total reinvestment commitment from operating cash flow.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Pharmena S.A. Cash Flow-to-Debt Ratio (2008–2024)
Historical debt coverage capacity for Pharmena S.A. across 17 annual periods. Also explore total assets of Pharmena S.A. for the complete picture of this company's asset base.
Annual Cash Flow-to-Debt Ratio for Pharmena S.A. (2008–2024)
Year-by-year debt coverage analysis for Pharmena S.A.. For market capitalisation and broader financial context, see PHR stock market capitalisation.
| Year | CF-to-Debt Ratio | Operating CF (PLN) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2024 | -2.29x | zł-2.53 Million | zł1.11 Million | ▼ -113.2% |
| 2023 | 17.33x | zł33.03 Million | zł1.91 Million | ▲ +18355.7% |
| 2022 | 0.09x | zł1.82 Million | zł19.37 Million | ▲ +147.4% |
| 2021 | -0.20x | zł-3.23 Million | zł16.27 Million | ▲ +0.2% |
| 2020 | -0.20x | zł-2.24 Million | zł11.30 Million | ▲ +89.8% |
| 2019 | -1.95x | zł-13.15 Million | zł6.74 Million | ▼ -362.6% |
| 2018 | 0.74x | zł3.61 Million | zł4.87 Million | ▲ +804.5% |
| 2017 | 0.08x | zł619.00K | zł7.54 Million | ▲ +172.1% |
| 2016 | -0.11x | zł-950.00K | zł8.34 Million | ▲ +82.3% |
| 2015 | -0.64x | zł-4.17 Million | zł6.49 Million | ▲ +57.7% |
| 2014 | -1.52x | zł-5.75 Million | zł3.78 Million | ▲ +0.6% |
| 2013 | -1.53x | zł-3.84 Million | zł2.51 Million | ▲ +1.5% |
| 2012 | -1.55x | zł-4.05 Million | zł2.61 Million | ▼ -472.2% |
| 2011 | 0.42x | zł666.91K | zł1.60 Million | ▲ +135.2% |
| 2010 | -1.18x | zł-1.08 Million | zł912.97K | ▼ -517.6% |
| 2009 | -0.19x | zł-179.22K | zł934.89K | ▼ -333.0% |
| 2008 | -0.04x | zł-32.56K | zł735.26K | — |